GlassScriptPhysician profile
Timothy M Coats
NPI 1386730737
$4,633.93
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,943 · 2020: $888 · 2021: $1,364 · 2022: $439.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $914.14 | 2019-2022 | |
| Novo Nordisk INC | $890.20 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $702.13 | 2019-2021 | |
| Glaxosmithkline, LLC. | $240.78 | 2019-2021 | |
| Abbvie INC. | $232.58 | 2019-2022 | |
| Amgen INC. | $222.19 | 2019-2022 | |
| Lilly USA, LLC | $197.20 | 2019-2022 | |
| Allergan, INC. | $168.61 | 2019-2020 | |
| Esperion Therapeutics, INC. | $157.36 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $120.87 | 2021 | |
| Sanofi-Aventis U.S. LLC | $114.18 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.89 | 2019-2022 | |
| Pfizer INC. | $105.20 | 2019-2022 | |
| Sanofi Pasteur INC. | $83.03 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $79.11 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $77.50 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $48.17 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $29.29 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $27.26 | 2019 | |
| Abbott Laboratories | $21.04 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.04 | 2022 | |
| Circassia INC. | $20.04 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.03 | 2019 | |
| Silk Road Medical, INC. | $15.48 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $13.61 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Coats listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.